Open official notice

Tamura Pharmaceuticals “Tafubon EX” - Recall

Official notice

24 Feb 2026

Last checked

27 Oct 2026

RecallScope risk estimate:MediumCAA Japan

An official CAA Japan notice concerns Tamura Pharmaceuticals “Tafubon EX” - Recall. The content of one active ingredient was found to be below the lower limit of the approved specification. Reason for recall: During stability monitoring of this product (at 42 months), the content of fursultiamine hydrochloride, one of the active ingredients, was found to be below the lower limit of the approved specification. We have therefore decided to voluntarily recall the affected lots listed above. Specific potential health effects: Because the content of fursultiamine hydrochloride is below the lower limit of the approved specification, the product's effectiveness may be reduced. However, we do not believe this issue poses a risk of serious adverse health effects. To date, we have received no reports of adverse health effects believed to be attributable to this issue. Published 2026-02-24.

What to do now

We have identified all recipients of shipments of the affected lots. We will notify them in writing of the recall and promptly carry out a voluntary recall.

Recall number

2-12692

Official notice

2026-02-24

The hazard

The content of one active ingredient was found to be below the lower limit of the approved specification. Reason for recall: During stability monitoring of this product (at 42 months), the content of fursultiamine hydrochloride, one of the active ingredients, was found to be below the lower limit of the approved specification. We have therefore decided to voluntarily recall the affected lots listed above. Specific potential health effects: Because the content of fursultiamine hydrochloride is below the lower limit of the approved specification, the product's effectiveness may be reduced. However, we do not believe this issue poses a risk of serious adverse health effects. To date, we have received no reports of adverse health effects believed to be attributable to this issue.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Recall Numbers

2-12692

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

タフボンEX

Hazard

The content of one active ingredient was found to be below the lower limit of the approved specification. Reason for recall: During stability monitoring of this product (at 42 months), the content of fursultiamine hydrochloride, one of the active ingredients, was found to be below the lower limit of the approved specification. We have therefore decided to voluntarily recall the affected lots listed above. Specific potential health effects: Because the content of fursultiamine hydrochloride is below the lower limit of the approved specification, the product's effectiveness may be reduced. However, we do not believe this issue poses a risk of serious adverse health effects. To date, we have received no reports of adverse health effects believed to be attributable to this issue.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Brand

田村薬品

Manufacturer

田村薬品工業株式会社

Phone

06-6203-5151

Brand: 田村薬品. Contact: 田村薬品工業株式会社 お客様相談室. Phone 06-6203-5151.

Source & status

Source

Tier

official

Category

HEALTH

Official classification

PMDA Class II — 回収

Recall details

Recall number

2-12692

Event id

CAA-00000034966

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 24 Feb 2026. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button